Small Molecule Videos

  1. Simtra BioPharma Solutions Capacity Update October 2025: ADC 8/7/2025

    MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.

  2. Designing IND-Enabling Toxicity Studies For Complex Drug Modalities 8/6/2025

    Traditional toxicity studies don’t always fit today’s complex drug modalities. Watch as experts discuss how we’re adapting small molecule IND-enabling studies to meet modern therapeutic challenges.

  3. Sustainability By Design In API Manufacturing 7/29/2025

    Explore the urgent need for sustainability in small molecule API manufacturing, as well as reveal regulatory drivers, green chemistry innovations, and practical strategies to reduce emissions.

  4. Upperton Pharma Solutions Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form 7/29/2025

    Ian Lafferty, CTO, and Josh Moule, Business Development Manager, talk through Upperton’s capabilities, project management approach and provide a virtual tour of their 60,000 sq. ft development and manufacturing facility.

  5. Quotient Sciences Capacity Update July 2025 7/29/2025

    Explore how expedited review pathways can be strategically used to accelerate development while mitigating CMC risks.

  6. PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form 7/29/2025

    Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.

  7. Your Boutique CDMO Partner Of Choice 7/29/2025

    Lora Wallis and Chris Cuthbertson highlight Douglas CDMO’s strengths in high-potency softgels and liquids and the company's 67 years of expertise and a client-centric approach.

  8. Comprehensive CDMO Services From Clinical To Commercial Supply 7/29/2025

    From world-class facilities across North America and Asia, high-quality drug products are manufactured and supplied to over 100 global markets, supporting patient and healthcare needs.

  9. MilliporeSigma Capacity Update July 2025: Small Molecule Drug Substance/API 7/29/2025

    Applications specialist John Stevens shows how MilliporeSigma is using their 35+ years of CDMO experience and expertise to move customers’ small molecules forward to the clinic and beyond to commercialization.

  10. Amorphous Solid Dispersions: Pre-Clinical To Commercial Capabilities 7/29/2025

    ASDs continue to be an attractive option for progressing and commercializing poorly soluble compounds. This talk focuses on capabilities to screen the potential for ASDs in early phase studies as well as their commercial applicability.